de Cliff Asness AMN Healthcare AMN Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 16.3 M | Comprar |
502,898
+198,608
| +65% | +USD 5.12 M | 0.01% | 1277 |
|
|
2026
Q1 | USD 5.58 M | Comprar |
304,290
+143,752
| +90% | +USD 2.73 M | ﹤0.01% | 1681 |
|
|
2025
Q4 | USD 2.53 M | Vender |
160,538
-31,352
| -16% | -USD 560 k | ﹤0.01% | 1989 |
|
|
2025
Q3 | USD 3.71 M | Vender |
191,890
-116,325
| -38% | -USD 2.27 M | ﹤0.01% | 1619 |
|
|
2025
Q2 | USD 6.37 M | Comprar |
308,215
+210,189
| +214% | +USD 4.37 M | 0.01% | 1156 |
|
|
2025
Q1 | USD 2.4 M | Comprar |
98,026
+34,465
| +54% | +USD 885 k | ﹤0.01% | 1510 |
|
|
2024
Q4 | USD 1.52 M | Comprar |
63,561
+49,252
| +344% | +USD 1.56 M | ﹤0.01% | 1668 |
|
|
2024
Q3 | USD 607 k | Vender |
14,309
-1,529
| -10% | -USD 80.2 k | ﹤0.01% | 2078 |
|
|
2024
Q2 | USD 811 k | Vender |
15,838
-13,744
| -46% | -USD 779 k | ﹤0.01% | 1845 |
|
|
2024
Q1 | USD 1.85 M | Comprar |
29,582
+4,268
| +17% | +USD 290 k | ﹤0.01% | 1452 |
|
|
2023
Q4 | USD 1.9 M | Vender |
25,314
-22,128
| -47% | -USD 1.58 M | ﹤0.01% | 1372 |
|
|
2023
Q3 | USD 4.04 M | Vender |
47,442
-7,345
| -13% | -USD 697 k | 0.01% | 1013 |
|
|
2023
Q2 | USD 5.98 M | Vender |
54,787
-49,163
| -47% | -USD 4.66 M | 0.01% | 834 |
|
|
2023
Q1 | USD 8.62 M | Comprar |
103,950
+36,320
| +54% | +USD 3.42 M | 0.02% | 693 |
|
|
2022
Q4 | USD 6.95 M | Vender |
67,630
-2,642
| -4% | -USD 304 k | 0.02% | 753 |
|
|
2022
Q3 | USD 7.45 M | Comprar |
70,272
+24,428
| +53% | +USD 2.68 M | 0.02% | 721 |
|
|
2022
Q2 | USD 5.03 M | Comprar |
45,844
+9,799
| +27% | +USD 970 k | 0.01% | 802 |
|
|
2022
Q1 | USD 3.76 M | Comprar |
36,045
+2,619
| +8% | +USD 272 k | 0.01% | 920 |
|
|
2021
Q4 | USD 4.09 M | Comprar |
33,426
+3,548
| +12% | +USD 394 k | 0.01% | 877 |
|
|
2021
Q3 | USD 3.43 M | Comprar |
29,878
+13,111
| +78% | +USD 1.39 M | 0.01% | 912 |
|
|
2021
Q2 | USD 1.63 M | Comprar |
16,767
+6,132
| +58% | +USD 532 k | ﹤0.01% | 1338 |
|
|
2021
Q1 | USD 784 k | Vender |
10,635
-9,999
| -48% | -USD 743 k | ﹤0.01% | 1658 |
|
|
2020
Q4 | USD 1.41 M | Vender |
20,634
-11,405
| -36% | -USD 744 k | ﹤0.01% | 1339 |
|
|
2020
Q3 | USD 1.87 M | Vender |
32,039
-19,954
| -38% | -USD 1.05 M | ﹤0.01% | 1142 |
|
|
2020
Q2 | USD 2.35 M | Comprar |
51,993
+23,715
| +84% | +USD 1.13 M | ﹤0.01% | 1089 |
|
|
2020
Q1 | USD 1.64 M | Vender |
28,278
-13,028
| -32% | -USD 892 k | ﹤0.01% | 1150 |
|
|
2019
Q4 | USD 2.57 M | Vender |
41,306
-4,819
| -10% | -USD 285 k | ﹤0.01% | 1174 |
|
|
2019
Q3 | USD 2.66 M | Comprar |
46,125
+2,197
| +5% | +USD 122 k | ﹤0.01% | 1179 |
|
|
2019
Q2 | USD 2.38 M | Vender |
43,928
-30,084
| -41% | -USD 1.53 M | ﹤0.01% | 1203 |
|
|
2019
Q1 | USD 3.48 M | Comprar |
74,012
+1,565
| +2% | +USD 86.8 k | ﹤0.01% | 1123 |
|
|
2018
Q4 | USD 4.1 M | Vender |
72,447
-12,143
| -14% | -USD 681 k | ﹤0.01% | 1006 |
|
|
2018
Q3 | USD 4.63 M | Vender |
84,590
-8,342
| -9% | -USD 478 k | ﹤0.01% | 1037 |
|
|
2018
Q2 | USD 5.45 M | Vender |
92,932
-13,257
| -12% | -USD 791 k | 0.01% | 992 |
|
|
2018
Q1 | USD 6.03 M | Vender |
106,189
-8,995
| -8% | -USD 489 k | 0.01% | 930 |
|
|
2017
Q4 | USD 5.67 M | Vender |
115,184
-13,960
| -11% | -USD 636 k | 0.01% | 987 |
|
|
2017
Q3 | USD 5.9 M | Comprar |
129,144
+22,924
| +22% | +USD 876 k | 0.01% | 959 |
|
|
2017
Q2 | USD 4.15 M | Comprar |
106,220
+10,839
| +11% | +USD 416 k | 0.01% | 1098 |
|
|
2017
Q1 | USD 3.87 M | Comprar |
95,381
+4,070
| +4% | +USD 159 k | 0.01% | 1122 |
|
|
2016
Q4 | USD 3.51 M | Vender |
91,311
-4,084
| -4% | -USD 140 k | ﹤0.01% | 1175 |
|
|
2016
Q3 | USD 3.04 M | Comprar |
95,395
+5,723
| +6% | +USD 217 k | ﹤0.01% | 1209 |
|
|
2016
Q2 | USD 3.58 M | Vender |
89,672
-1,911
| -2% | -USD 70.7 k | 0.01% | 1042 |
|
|
2016
Q1 | USD 3.08 M | Comprar |
91,583
+28,371
| +45% | +USD 811 k | 0.01% | 1056 |
|
|
2015
Q4 | USD 1.96 M | Comprar |
63,212
+18,614
| +42% | +USD 551 k | ﹤0.01% | 1249 |
|
|
2015
Q3 | USD 1.34 M | Comprar |
44,598
+2,949
| +7% | +USD 97.3 k | ﹤0.01% | 1297 |
|
|
2015
Q2 | USD 1.32 M | Comprar |
41,649
+10,206
| +32% | +USD 267 k | ﹤0.01% | 1371 |
|
|
2015
Q1 | USD 725 k | Comprar |
31,443
+17,300
| +122% | +USD 358 k | ﹤0.01% | 1554 |
|
|
2014
Q4 | USD 277 k | Vender |
14,143
-35,944
| -72% | -USD 617 k | ﹤0.01% | 2240 |
|
|
2014
Q3 | USD 786 k | Vender |
50,087
-42,800
| -46% | -USD 610 k | ﹤0.01% | 1735 |
|
|
2014
Q2 | USD 1.14 M | Vender |
92,887
-85,791
| -48% | -USD 1.03 M | ﹤0.01% | 1584 |
|
|
2014
Q1 | USD 2.46 M | Comprar |
178,678
+2,700
| +2% | +USD 38.9 k | 0.01% | 1182 |
|
|
2013
Q4 | USD 2.59 M | Comprar |
175,978
+5,930
| +3% | +USD 80.3 k | 0.01% | 1200 |
|
|
2013
Q3 | USD 2.34 M | Comprar |
170,048
+96,761
| +132% | +USD 1.42 M | 0.01% | 1188 |
|
|
2013
Q2 | USD 1.05 M | Comprar |
+73,287
| Nuevas | +USD 1.03 M | ﹤0.01% | 1551 |
|
Otros fondos que tienen AMN en su cartera
Posición de Cliff Asness en AMN: resumen de T2 2026
Cliff Asness aumentó su participación en AMN Healthcare (AMN) en 65% durante T2 2026, al comprar aproximadamente USD 5.12 M y elevar la posición a 502,898 acciones con un valor de USD 16.3 M. La posición representa 0.01% de la cartera y ocupa el puesto #1277.
Cliff Asness reportó por primera vez una posición en AMN en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 285 fondos que sigue Wall St. Rank mantienen una posición en AMN.
- Al cierre de T2 2026, Cliff Asness tenía 502,898 acciones de AMN Healthcare con un valor de USD 16.3 M.
- Cliff Asness compró 198,608 acciones de AMN Healthcare en T2 2026, por un monto estimado de USD 5.12 M.
- AMN Healthcare representó 0.01% de la cartera de Cliff Asness en T2 2026 y fue su posición número 1277.
- Cliff Asness reportó por primera vez una posición en AMN Healthcare en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 285 fondos que sigue Wall St. Rank tenían AMN Healthcare en cartera.
Según el Informe 13F de AQR Capital Management correspondiente a T2 2026, presentado el 14 ago 2026.